Skip to content

Cardiovascular risk reduction using an Ayurvedic protocol

Role of an Ayurvedic Primary Prevention Protocol in reduction of risk for Cardiovascular disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/10/021661
Enrollment
100
Registered
2019-10-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I998- Other disorder of circulatory system

Interventions

Intervention1: Ayurvedic Primary Prevention Protocol and Life Style modification: Vaiswanara Choornam - 6 gm bid X 7 days,Gandharvahasthadi Kashayam- 60 ml bid X 14 days ,Gandharvaeranda Thailam -5 dr

Sponsors

Directorate of Ayurveda Medical Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: subjects not diagnosed of any CVD complications like CAD, CVA, Renal artery disease, Peripheral artery disease Subjects below 30% risk according to WHO/ISH risk prediction chart

Exclusion criteria

Exclusion criteria: 1.Participants above 30% of risk, not under any medications for the co-morbidities. (30% and above has been recommended as the limit for non-pharmacological measures of life style modification). 2.Participants with established renal diseases 3.Participants with any acute clinically overt diseases 4.Participants with total cholesterol level � 320 mg/dl 5.Participants with low-density lipoprotein (LDL) cholesterol � 240 mg/dl or TC/HDL-C (total cholesterol / high density lipoprotein cholesterol) ratio > 8

Design outcomes

Primary

MeasureTime frame
CVD risk scoreTimepoint: 49 days

Secondary

MeasureTime frame
BMI,Blood Pressure,Lipid ProfileTimepoint: 49 days

Countries

India

Contacts

Public ContactDr Radhika Rani R K

Govt Ayurveda College, Puthiyakavu, Tripunithura.

drradhekarani@yahoo.co.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 5, 2026